Global Mesalazine API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Mesalazine API Industry Forecast” looks at past sales and reviews total world Mesalazine API sales in 2022, providing a comprehensive analysis by region and market sector of projected Mesalazine API sales for 2023 through 2029. With Mesalazine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine API industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mesalazine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine API and breaks down the forecast by purity, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine API.
The global Mesalazine API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mesalazine API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mesalazine API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mesalazine API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mesalazine API players cover PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm and Lasa Loboratory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine API market by product purity, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by purity
What is the 10-year outlook for the global Mesalazine API market?
What factors are driving Mesalazine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalazine API market opportunities vary by end market size?
How does Mesalazine API break out purity, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Mesalazine API Industry Forecast” looks at past sales and reviews total world Mesalazine API sales in 2022, providing a comprehensive analysis by region and market sector of projected Mesalazine API sales for 2023 through 2029. With Mesalazine API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mesalazine API industry.
This Insight Report provides a comprehensive analysis of the global Mesalazine API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mesalazine API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Mesalazine API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mesalazine API and breaks down the forecast by purity, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mesalazine API.
The global Mesalazine API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Mesalazine API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Mesalazine API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Mesalazine API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Mesalazine API players cover PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm and Lasa Loboratory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalazine API market by product purity, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by purity
- Above 97 %
- Above 98 %
- Above 99 %
- Tablets
- Capsules
- Granule
- Suppository
- Enema
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PharmaZell
- Syntese A/S
- Cambrex Corporation
- Divis Laboratories
- Chemi SpA
- Ipca Laboratories
- Hangzhou Brother
- Lianyungang Fengheng Biopharm
- Lasa Loboratory
- Corden Pharma Bergamo
- Erregierre SpA
- CTX Lifescience
- Ishita Active Pharma Ingredients
- YC Biotech (Jiangsu)
- Xinxiang Tianfeng Fine Chemical
What is the 10-year outlook for the global Mesalazine API market?
What factors are driving Mesalazine API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Mesalazine API market opportunities vary by end market size?
How does Mesalazine API break out purity, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalazine API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mesalazine API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mesalazine API by Country/Region, 2018, 2022 & 2029
2.2 Mesalazine API Segment by Purity
2.2.1 Above 97 %
2.2.2 Above 98 %
2.2.3 Above 99 %
2.3 Mesalazine API Sales by Purity
2.3.1 Global Mesalazine API Sales Market Share by Purity (2018-2023)
2.3.2 Global Mesalazine API Revenue and Market Share by Purity (2018-2023)
2.3.3 Global Mesalazine API Sale Price by Purity (2018-2023)
2.4 Mesalazine API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalazine API Sales by Application
2.5.1 Global Mesalazine API Sale Market Share by Application (2018-2023)
2.5.2 Global Mesalazine API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mesalazine API Sale Price by Application (2018-2023)
3 GLOBAL MESALAZINE API BY COMPANY
3.1 Global Mesalazine API Breakdown Data by Company
3.1.1 Global Mesalazine API Annual Sales by Company (2018-2023)
3.1.2 Global Mesalazine API Sales Market Share by Company (2018-2023)
3.2 Global Mesalazine API Annual Revenue by Company (2018-2023)
3.2.1 Global Mesalazine API Revenue by Company (2018-2023)
3.2.2 Global Mesalazine API Revenue Market Share by Company (2018-2023)
3.3 Global Mesalazine API Sale Price by Company
3.4 Key Manufacturers Mesalazine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine API Product Location Distribution
3.4.2 Players Mesalazine API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
4.1 World Historic Mesalazine API Market Size by Geographic Region (2018-2023)
4.1.1 Global Mesalazine API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mesalazine API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mesalazine API Market Size by Country/Region (2018-2023)
4.2.1 Global Mesalazine API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mesalazine API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mesalazine API Sales Growth
4.4 APAC Mesalazine API Sales Growth
4.5 Europe Mesalazine API Sales Growth
4.6 Middle East & Africa Mesalazine API Sales Growth
5 AMERICAS
5.1 Americas Mesalazine API Sales by Country
5.1.1 Americas Mesalazine API Sales by Country (2018-2023)
5.1.2 Americas Mesalazine API Revenue by Country (2018-2023)
5.2 Americas Mesalazine API Sales by Purity
5.3 Americas Mesalazine API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine API Sales by Region
6.1.1 APAC Mesalazine API Sales by Region (2018-2023)
6.1.2 APAC Mesalazine API Revenue by Region (2018-2023)
6.2 APAC Mesalazine API Sales by Purity
6.3 APAC Mesalazine API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalazine API by Country
7.1.1 Europe Mesalazine API Sales by Country (2018-2023)
7.1.2 Europe Mesalazine API Revenue by Country (2018-2023)
7.2 Europe Mesalazine API Sales by Purity
7.3 Europe Mesalazine API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalazine API by Country
8.1.1 Middle East & Africa Mesalazine API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mesalazine API Revenue by Country (2018-2023)
8.2 Middle East & Africa Mesalazine API Sales by Purity
8.3 Middle East & Africa Mesalazine API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine API
10.3 Manufacturing Process Analysis of Mesalazine API
10.4 Industry Chain Structure of Mesalazine API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine API Distributors
11.3 Mesalazine API Customer
12 WORLD FORECAST REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
12.1 Global Mesalazine API Market Size Forecast by Region
12.1.1 Global Mesalazine API Forecast by Region (2024-2029)
12.1.2 Global Mesalazine API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mesalazine API Forecast by Purity
12.7 Global Mesalazine API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalazine API Product Portfolios and Specifications
13.1.3 PharmaZell Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalazine API Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalazine API Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalazine API Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalazine API Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalazine API Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalazine API Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalazine API Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalazine API Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalazine API Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Mesalazine API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Mesalazine API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Mesalazine API by Country/Region, 2018, 2022 & 2029
2.2 Mesalazine API Segment by Purity
2.2.1 Above 97 %
2.2.2 Above 98 %
2.2.3 Above 99 %
2.3 Mesalazine API Sales by Purity
2.3.1 Global Mesalazine API Sales Market Share by Purity (2018-2023)
2.3.2 Global Mesalazine API Revenue and Market Share by Purity (2018-2023)
2.3.3 Global Mesalazine API Sale Price by Purity (2018-2023)
2.4 Mesalazine API Segment by Application
2.4.1 Tablets
2.4.2 Capsules
2.4.3 Granule
2.4.4 Suppository
2.4.5 Enema
2.4.6 Others
2.5 Mesalazine API Sales by Application
2.5.1 Global Mesalazine API Sale Market Share by Application (2018-2023)
2.5.2 Global Mesalazine API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Mesalazine API Sale Price by Application (2018-2023)
3 GLOBAL MESALAZINE API BY COMPANY
3.1 Global Mesalazine API Breakdown Data by Company
3.1.1 Global Mesalazine API Annual Sales by Company (2018-2023)
3.1.2 Global Mesalazine API Sales Market Share by Company (2018-2023)
3.2 Global Mesalazine API Annual Revenue by Company (2018-2023)
3.2.1 Global Mesalazine API Revenue by Company (2018-2023)
3.2.2 Global Mesalazine API Revenue Market Share by Company (2018-2023)
3.3 Global Mesalazine API Sale Price by Company
3.4 Key Manufacturers Mesalazine API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mesalazine API Product Location Distribution
3.4.2 Players Mesalazine API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
4.1 World Historic Mesalazine API Market Size by Geographic Region (2018-2023)
4.1.1 Global Mesalazine API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Mesalazine API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Mesalazine API Market Size by Country/Region (2018-2023)
4.2.1 Global Mesalazine API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Mesalazine API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Mesalazine API Sales Growth
4.4 APAC Mesalazine API Sales Growth
4.5 Europe Mesalazine API Sales Growth
4.6 Middle East & Africa Mesalazine API Sales Growth
5 AMERICAS
5.1 Americas Mesalazine API Sales by Country
5.1.1 Americas Mesalazine API Sales by Country (2018-2023)
5.1.2 Americas Mesalazine API Revenue by Country (2018-2023)
5.2 Americas Mesalazine API Sales by Purity
5.3 Americas Mesalazine API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalazine API Sales by Region
6.1.1 APAC Mesalazine API Sales by Region (2018-2023)
6.1.2 APAC Mesalazine API Revenue by Region (2018-2023)
6.2 APAC Mesalazine API Sales by Purity
6.3 APAC Mesalazine API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Mesalazine API by Country
7.1.1 Europe Mesalazine API Sales by Country (2018-2023)
7.1.2 Europe Mesalazine API Revenue by Country (2018-2023)
7.2 Europe Mesalazine API Sales by Purity
7.3 Europe Mesalazine API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Mesalazine API by Country
8.1.1 Middle East & Africa Mesalazine API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Mesalazine API Revenue by Country (2018-2023)
8.2 Middle East & Africa Mesalazine API Sales by Purity
8.3 Middle East & Africa Mesalazine API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mesalazine API
10.3 Manufacturing Process Analysis of Mesalazine API
10.4 Industry Chain Structure of Mesalazine API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mesalazine API Distributors
11.3 Mesalazine API Customer
12 WORLD FORECAST REVIEW FOR MESALAZINE API BY GEOGRAPHIC REGION
12.1 Global Mesalazine API Market Size Forecast by Region
12.1.1 Global Mesalazine API Forecast by Region (2024-2029)
12.1.2 Global Mesalazine API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mesalazine API Forecast by Purity
12.7 Global Mesalazine API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 PharmaZell
13.1.1 PharmaZell Company Information
13.1.2 PharmaZell Mesalazine API Product Portfolios and Specifications
13.1.3 PharmaZell Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 PharmaZell Main Business Overview
13.1.5 PharmaZell Latest Developments
13.2 Syntese A/S
13.2.1 Syntese A/S Company Information
13.2.2 Syntese A/S Mesalazine API Product Portfolios and Specifications
13.2.3 Syntese A/S Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Syntese A/S Main Business Overview
13.2.5 Syntese A/S Latest Developments
13.3 Cambrex Corporation
13.3.1 Cambrex Corporation Company Information
13.3.2 Cambrex Corporation Mesalazine API Product Portfolios and Specifications
13.3.3 Cambrex Corporation Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cambrex Corporation Main Business Overview
13.3.5 Cambrex Corporation Latest Developments
13.4 Divis Laboratories
13.4.1 Divis Laboratories Company Information
13.4.2 Divis Laboratories Mesalazine API Product Portfolios and Specifications
13.4.3 Divis Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Divis Laboratories Main Business Overview
13.4.5 Divis Laboratories Latest Developments
13.5 Chemi SpA
13.5.1 Chemi SpA Company Information
13.5.2 Chemi SpA Mesalazine API Product Portfolios and Specifications
13.5.3 Chemi SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chemi SpA Main Business Overview
13.5.5 Chemi SpA Latest Developments
13.6 Ipca Laboratories
13.6.1 Ipca Laboratories Company Information
13.6.2 Ipca Laboratories Mesalazine API Product Portfolios and Specifications
13.6.3 Ipca Laboratories Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Ipca Laboratories Main Business Overview
13.6.5 Ipca Laboratories Latest Developments
13.7 Hangzhou Brother
13.7.1 Hangzhou Brother Company Information
13.7.2 Hangzhou Brother Mesalazine API Product Portfolios and Specifications
13.7.3 Hangzhou Brother Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hangzhou Brother Main Business Overview
13.7.5 Hangzhou Brother Latest Developments
13.8 Lianyungang Fengheng Biopharm
13.8.1 Lianyungang Fengheng Biopharm Company Information
13.8.2 Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
13.8.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Lianyungang Fengheng Biopharm Main Business Overview
13.8.5 Lianyungang Fengheng Biopharm Latest Developments
13.9 Lasa Loboratory
13.9.1 Lasa Loboratory Company Information
13.9.2 Lasa Loboratory Mesalazine API Product Portfolios and Specifications
13.9.3 Lasa Loboratory Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Lasa Loboratory Main Business Overview
13.9.5 Lasa Loboratory Latest Developments
13.10 Corden Pharma Bergamo
13.10.1 Corden Pharma Bergamo Company Information
13.10.2 Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
13.10.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Corden Pharma Bergamo Main Business Overview
13.10.5 Corden Pharma Bergamo Latest Developments
13.11 Erregierre SpA
13.11.1 Erregierre SpA Company Information
13.11.2 Erregierre SpA Mesalazine API Product Portfolios and Specifications
13.11.3 Erregierre SpA Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Erregierre SpA Main Business Overview
13.11.5 Erregierre SpA Latest Developments
13.12 CTX Lifescience
13.12.1 CTX Lifescience Company Information
13.12.2 CTX Lifescience Mesalazine API Product Portfolios and Specifications
13.12.3 CTX Lifescience Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 CTX Lifescience Main Business Overview
13.12.5 CTX Lifescience Latest Developments
13.13 Ishita Active Pharma Ingredients
13.13.1 Ishita Active Pharma Ingredients Company Information
13.13.2 Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
13.13.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Ishita Active Pharma Ingredients Main Business Overview
13.13.5 Ishita Active Pharma Ingredients Latest Developments
13.14 YC Biotech (Jiangsu)
13.14.1 YC Biotech (Jiangsu) Company Information
13.14.2 YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
13.14.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 YC Biotech (Jiangsu) Main Business Overview
13.14.5 YC Biotech (Jiangsu) Latest Developments
13.15 Xinxiang Tianfeng Fine Chemical
13.15.1 Xinxiang Tianfeng Fine Chemical Company Information
13.15.2 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
13.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Xinxiang Tianfeng Fine Chemical Main Business Overview
13.15.5 Xinxiang Tianfeng Fine Chemical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Mesalazine API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mesalazine API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 97 %
Table 4. Major Players of Above 98 %
Table 5. Major Players of Above 99 %
Table 6. Global Mesalazine API Sales by Purity (2018-2023) & (Tons)
Table 7. Global Mesalazine API Sales Market Share by Purity (2018-2023)
Table 8. Global Mesalazine API Revenue by Purity (2018-2023) & ($ million)
Table 9. Global Mesalazine API Revenue Market Share by Purity (2018-2023)
Table 10. Global Mesalazine API Sale Price by Purity (2018-2023) & (US$/Ton)
Table 11. Global Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 12. Global Mesalazine API Sales Market Share by Application (2018-2023)
Table 13. Global Mesalazine API Revenue by Application (2018-2023)
Table 14. Global Mesalazine API Revenue Market Share by Application (2018-2023)
Table 15. Global Mesalazine API Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Mesalazine API Sales by Company (2018-2023) & (Tons)
Table 17. Global Mesalazine API Sales Market Share by Company (2018-2023)
Table 18. Global Mesalazine API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Mesalazine API Revenue Market Share by Company (2018-2023)
Table 20. Global Mesalazine API Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Mesalazine API Producing Area Distribution and Sales Area
Table 22. Players Mesalazine API Products Offered
Table 23. Mesalazine API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Mesalazine API Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global Mesalazine API Sales Market Share Geographic Region (2018-2023)
Table 28. Global Mesalazine API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Mesalazine API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Mesalazine API Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global Mesalazine API Sales Market Share by Country/Region (2018-2023)
Table 32. Global Mesalazine API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Mesalazine API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Mesalazine API Sales by Country (2018-2023) & (Tons)
Table 35. Americas Mesalazine API Sales Market Share by Country (2018-2023)
Table 36. Americas Mesalazine API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Mesalazine API Revenue Market Share by Country (2018-2023)
Table 38. Americas Mesalazine API Sales by Type (2018-2023) & (Tons)
Table 39. Americas Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 40. APAC Mesalazine API Sales by Region (2018-2023) & (Tons)
Table 41. APAC Mesalazine API Sales Market Share by Region (2018-2023)
Table 42. APAC Mesalazine API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Mesalazine API Revenue Market Share by Region (2018-2023)
Table 44. APAC Mesalazine API Sales by Purity (2018-2023) & (Tons)
Table 45. APAC Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 46. Europe Mesalazine API Sales by Country (2018-2023) & (Tons)
Table 47. Europe Mesalazine API Sales Market Share by Country (2018-2023)
Table 48. Europe Mesalazine API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Mesalazine API Revenue Market Share by Country (2018-2023)
Table 50. Europe Mesalazine API Sales by Type (2018-2023) & (Tons)
Table 51. Europe Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa Mesalazine API Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa Mesalazine API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Mesalazine API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Mesalazine API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Mesalazine API Sales by Purity (2018-2023) & (Tons)
Table 57. Middle East & Africa Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Mesalazine API
Table 59. Key Market Challenges & Risks of Mesalazine API
Table 60. Key Industry Trends of Mesalazine API
Table 61. Mesalazine API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Mesalazine API Distributors List
Table 64. Mesalazine API Customer List
Table 65. Global Mesalazine API Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global Mesalazine API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Mesalazine API Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas Mesalazine API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Mesalazine API Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC Mesalazine API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Mesalazine API Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe Mesalazine API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Mesalazine API Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa Mesalazine API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Mesalazine API Sales Forecast by Purity (2024-2029) & (Tons)
Table 76. Global Mesalazine API Revenue Forecast by Purity (2024-2029) & ($ Millions)
Table 77. Global Mesalazine API Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global Mesalazine API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. PharmaZell Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 80. PharmaZell Mesalazine API Product Portfolios and Specifications
Table 81. PharmaZell Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. PharmaZell Main Business
Table 83. PharmaZell Latest Developments
Table 84. Syntese A/S Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 85. Syntese A/S Mesalazine API Product Portfolios and Specifications
Table 86. Syntese A/S Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Syntese A/S Main Business
Table 88. Syntese A/S Latest Developments
Table 89. Cambrex Corporation Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 90. Cambrex Corporation Mesalazine API Product Portfolios and Specifications
Table 91. Cambrex Corporation Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Cambrex Corporation Main Business
Table 93. Cambrex Corporation Latest Developments
Table 94. Divis Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 95. Divis Laboratories Mesalazine API Product Portfolios and Specifications
Table 96. Divis Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Divis Laboratories Main Business
Table 98. Divis Laboratories Latest Developments
Table 99. Chemi SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 100. Chemi SpA Mesalazine API Product Portfolios and Specifications
Table 101. Chemi SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Chemi SpA Main Business
Table 103. Chemi SpA Latest Developments
Table 104. Ipca Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 105. Ipca Laboratories Mesalazine API Product Portfolios and Specifications
Table 106. Ipca Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Ipca Laboratories Main Business
Table 108. Ipca Laboratories Latest Developments
Table 109. Hangzhou Brother Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 110. Hangzhou Brother Mesalazine API Product Portfolios and Specifications
Table 111. Hangzhou Brother Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Hangzhou Brother Main Business
Table 113. Hangzhou Brother Latest Developments
Table 114. Lianyungang Fengheng Biopharm Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 115. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
Table 116. Lianyungang Fengheng Biopharm Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Lianyungang Fengheng Biopharm Main Business
Table 118. Lianyungang Fengheng Biopharm Latest Developments
Table 119. Lasa Loboratory Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 120. Lasa Loboratory Mesalazine API Product Portfolios and Specifications
Table 121. Lasa Loboratory Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Lasa Loboratory Main Business
Table 123. Lasa Loboratory Latest Developments
Table 124. Corden Pharma Bergamo Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 125. Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
Table 126. Corden Pharma Bergamo Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Corden Pharma Bergamo Main Business
Table 128. Corden Pharma Bergamo Latest Developments
Table 129. Erregierre SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 130. Erregierre SpA Mesalazine API Product Portfolios and Specifications
Table 131. Erregierre SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Erregierre SpA Main Business
Table 133. Erregierre SpA Latest Developments
Table 134. CTX Lifescience Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 135. CTX Lifescience Mesalazine API Product Portfolios and Specifications
Table 136. CTX Lifescience Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. CTX Lifescience Main Business
Table 138. CTX Lifescience Latest Developments
Table 139. Ishita Active Pharma Ingredients Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 140. Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
Table 141. Ishita Active Pharma Ingredients Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 142. Ishita Active Pharma Ingredients Main Business
Table 143. Ishita Active Pharma Ingredients Latest Developments
Table 144. YC Biotech (Jiangsu) Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 145. YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
Table 146. YC Biotech (Jiangsu) Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 147. YC Biotech (Jiangsu) Main Business
Table 148. YC Biotech (Jiangsu) Latest Developments
Table 149. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 150. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
Table 151. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 152. Xinxiang Tianfeng Fine Chemical Main Business
Table 153. Xinxiang Tianfeng Fine Chemical Latest Developments
Table 1. Mesalazine API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Mesalazine API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Above 97 %
Table 4. Major Players of Above 98 %
Table 5. Major Players of Above 99 %
Table 6. Global Mesalazine API Sales by Purity (2018-2023) & (Tons)
Table 7. Global Mesalazine API Sales Market Share by Purity (2018-2023)
Table 8. Global Mesalazine API Revenue by Purity (2018-2023) & ($ million)
Table 9. Global Mesalazine API Revenue Market Share by Purity (2018-2023)
Table 10. Global Mesalazine API Sale Price by Purity (2018-2023) & (US$/Ton)
Table 11. Global Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 12. Global Mesalazine API Sales Market Share by Application (2018-2023)
Table 13. Global Mesalazine API Revenue by Application (2018-2023)
Table 14. Global Mesalazine API Revenue Market Share by Application (2018-2023)
Table 15. Global Mesalazine API Sale Price by Application (2018-2023) & (US$/Ton)
Table 16. Global Mesalazine API Sales by Company (2018-2023) & (Tons)
Table 17. Global Mesalazine API Sales Market Share by Company (2018-2023)
Table 18. Global Mesalazine API Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Mesalazine API Revenue Market Share by Company (2018-2023)
Table 20. Global Mesalazine API Sale Price by Company (2018-2023) & (US$/Ton)
Table 21. Key Manufacturers Mesalazine API Producing Area Distribution and Sales Area
Table 22. Players Mesalazine API Products Offered
Table 23. Mesalazine API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Mesalazine API Sales by Geographic Region (2018-2023) & (Tons)
Table 27. Global Mesalazine API Sales Market Share Geographic Region (2018-2023)
Table 28. Global Mesalazine API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Mesalazine API Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Mesalazine API Sales by Country/Region (2018-2023) & (Tons)
Table 31. Global Mesalazine API Sales Market Share by Country/Region (2018-2023)
Table 32. Global Mesalazine API Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Mesalazine API Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Mesalazine API Sales by Country (2018-2023) & (Tons)
Table 35. Americas Mesalazine API Sales Market Share by Country (2018-2023)
Table 36. Americas Mesalazine API Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Mesalazine API Revenue Market Share by Country (2018-2023)
Table 38. Americas Mesalazine API Sales by Type (2018-2023) & (Tons)
Table 39. Americas Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 40. APAC Mesalazine API Sales by Region (2018-2023) & (Tons)
Table 41. APAC Mesalazine API Sales Market Share by Region (2018-2023)
Table 42. APAC Mesalazine API Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Mesalazine API Revenue Market Share by Region (2018-2023)
Table 44. APAC Mesalazine API Sales by Purity (2018-2023) & (Tons)
Table 45. APAC Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 46. Europe Mesalazine API Sales by Country (2018-2023) & (Tons)
Table 47. Europe Mesalazine API Sales Market Share by Country (2018-2023)
Table 48. Europe Mesalazine API Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Mesalazine API Revenue Market Share by Country (2018-2023)
Table 50. Europe Mesalazine API Sales by Type (2018-2023) & (Tons)
Table 51. Europe Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 52. Middle East & Africa Mesalazine API Sales by Country (2018-2023) & (Tons)
Table 53. Middle East & Africa Mesalazine API Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Mesalazine API Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Mesalazine API Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Mesalazine API Sales by Purity (2018-2023) & (Tons)
Table 57. Middle East & Africa Mesalazine API Sales by Application (2018-2023) & (Tons)
Table 58. Key Market Drivers & Growth Opportunities of Mesalazine API
Table 59. Key Market Challenges & Risks of Mesalazine API
Table 60. Key Industry Trends of Mesalazine API
Table 61. Mesalazine API Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Mesalazine API Distributors List
Table 64. Mesalazine API Customer List
Table 65. Global Mesalazine API Sales Forecast by Region (2024-2029) & (Tons)
Table 66. Global Mesalazine API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Mesalazine API Sales Forecast by Country (2024-2029) & (Tons)
Table 68. Americas Mesalazine API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Mesalazine API Sales Forecast by Region (2024-2029) & (Tons)
Table 70. APAC Mesalazine API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Mesalazine API Sales Forecast by Country (2024-2029) & (Tons)
Table 72. Europe Mesalazine API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Mesalazine API Sales Forecast by Country (2024-2029) & (Tons)
Table 74. Middle East & Africa Mesalazine API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Mesalazine API Sales Forecast by Purity (2024-2029) & (Tons)
Table 76. Global Mesalazine API Revenue Forecast by Purity (2024-2029) & ($ Millions)
Table 77. Global Mesalazine API Sales Forecast by Application (2024-2029) & (Tons)
Table 78. Global Mesalazine API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. PharmaZell Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 80. PharmaZell Mesalazine API Product Portfolios and Specifications
Table 81. PharmaZell Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 82. PharmaZell Main Business
Table 83. PharmaZell Latest Developments
Table 84. Syntese A/S Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 85. Syntese A/S Mesalazine API Product Portfolios and Specifications
Table 86. Syntese A/S Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 87. Syntese A/S Main Business
Table 88. Syntese A/S Latest Developments
Table 89. Cambrex Corporation Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 90. Cambrex Corporation Mesalazine API Product Portfolios and Specifications
Table 91. Cambrex Corporation Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 92. Cambrex Corporation Main Business
Table 93. Cambrex Corporation Latest Developments
Table 94. Divis Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 95. Divis Laboratories Mesalazine API Product Portfolios and Specifications
Table 96. Divis Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 97. Divis Laboratories Main Business
Table 98. Divis Laboratories Latest Developments
Table 99. Chemi SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 100. Chemi SpA Mesalazine API Product Portfolios and Specifications
Table 101. Chemi SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 102. Chemi SpA Main Business
Table 103. Chemi SpA Latest Developments
Table 104. Ipca Laboratories Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 105. Ipca Laboratories Mesalazine API Product Portfolios and Specifications
Table 106. Ipca Laboratories Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 107. Ipca Laboratories Main Business
Table 108. Ipca Laboratories Latest Developments
Table 109. Hangzhou Brother Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 110. Hangzhou Brother Mesalazine API Product Portfolios and Specifications
Table 111. Hangzhou Brother Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 112. Hangzhou Brother Main Business
Table 113. Hangzhou Brother Latest Developments
Table 114. Lianyungang Fengheng Biopharm Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 115. Lianyungang Fengheng Biopharm Mesalazine API Product Portfolios and Specifications
Table 116. Lianyungang Fengheng Biopharm Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 117. Lianyungang Fengheng Biopharm Main Business
Table 118. Lianyungang Fengheng Biopharm Latest Developments
Table 119. Lasa Loboratory Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 120. Lasa Loboratory Mesalazine API Product Portfolios and Specifications
Table 121. Lasa Loboratory Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 122. Lasa Loboratory Main Business
Table 123. Lasa Loboratory Latest Developments
Table 124. Corden Pharma Bergamo Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 125. Corden Pharma Bergamo Mesalazine API Product Portfolios and Specifications
Table 126. Corden Pharma Bergamo Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 127. Corden Pharma Bergamo Main Business
Table 128. Corden Pharma Bergamo Latest Developments
Table 129. Erregierre SpA Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 130. Erregierre SpA Mesalazine API Product Portfolios and Specifications
Table 131. Erregierre SpA Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 132. Erregierre SpA Main Business
Table 133. Erregierre SpA Latest Developments
Table 134. CTX Lifescience Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 135. CTX Lifescience Mesalazine API Product Portfolios and Specifications
Table 136. CTX Lifescience Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 137. CTX Lifescience Main Business
Table 138. CTX Lifescience Latest Developments
Table 139. Ishita Active Pharma Ingredients Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 140. Ishita Active Pharma Ingredients Mesalazine API Product Portfolios and Specifications
Table 141. Ishita Active Pharma Ingredients Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 142. Ishita Active Pharma Ingredients Main Business
Table 143. Ishita Active Pharma Ingredients Latest Developments
Table 144. YC Biotech (Jiangsu) Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 145. YC Biotech (Jiangsu) Mesalazine API Product Portfolios and Specifications
Table 146. YC Biotech (Jiangsu) Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 147. YC Biotech (Jiangsu) Main Business
Table 148. YC Biotech (Jiangsu) Latest Developments
Table 149. Xinxiang Tianfeng Fine Chemical Basic Information, Mesalazine API Manufacturing Base, Sales Area and Its Competitors
Table 150. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Portfolios and Specifications
Table 151. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 152. Xinxiang Tianfeng Fine Chemical Main Business
Table 153. Xinxiang Tianfeng Fine Chemical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Mesalazine API
Figure 2. Mesalazine API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Mesalazine API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mesalazine API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 97 %
Figure 10. Product Picture of Above 98 %
Figure 11. Product Picture of Above 99 %
Figure 12. Global Mesalazine API Sales Market Share by Purity in 2022
Figure 13. Global Mesalazine API Revenue Market Share by Purity (2018-2023)
Figure 14. Mesalazine API Consumed in Tablets
Figure 15. Global Mesalazine API Market: Tablets (2018-2023) & (Tons)
Figure 16. Mesalazine API Consumed in Capsules
Figure 17. Global Mesalazine API Market: Capsules (2018-2023) & (Tons)
Figure 18. Mesalazine API Consumed in Granule
Figure 19. Global Mesalazine API Market: Granule (2018-2023) & (Tons)
Figure 20. Mesalazine API Consumed in Suppository
Figure 21. Global Mesalazine API Market: Suppository (2018-2023) & (Tons)
Figure 22. Mesalazine API Consumed in Enema
Figure 23. Global Mesalazine API Market: Enema (2018-2023) & (Tons)
Figure 24. Mesalazine API Consumed in Others
Figure 25. Global Mesalazine API Market: Others (2018-2023) & (Tons)
Figure 26. Global Mesalazine API Sales Market Share by Application (2022)
Figure 27. Global Mesalazine API Revenue Market Share by Application in 2022
Figure 28. Mesalazine API Sales Market by Company in 2022 (Tons)
Figure 29. Global Mesalazine API Sales Market Share by Company in 2022
Figure 30. Mesalazine API Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Mesalazine API Revenue Market Share by Company in 2022
Figure 32. Global Mesalazine API Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Mesalazine API Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Mesalazine API Sales 2018-2023 (Tons)
Figure 35. Americas Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 36. APAC Mesalazine API Sales 2018-2023 (Tons)
Figure 37. APAC Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 38. Europe Mesalazine API Sales 2018-2023 (Tons)
Figure 39. Europe Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Mesalazine API Sales 2018-2023 (Tons)
Figure 41. Middle East & Africa Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 42. Americas Mesalazine API Sales Market Share by Country in 2022
Figure 43. Americas Mesalazine API Revenue Market Share by Country in 2022
Figure 44. Americas Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 45. Americas Mesalazine API Sales Market Share by Application (2018-2023)
Figure 46. United States Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Mesalazine API Sales Market Share by Region in 2022
Figure 51. APAC Mesalazine API Revenue Market Share by Regions in 2022
Figure 52. APAC Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 53. APAC Mesalazine API Sales Market Share by Application (2018-2023)
Figure 54. China Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Mesalazine API Sales Market Share by Country in 2022
Figure 62. Europe Mesalazine API Revenue Market Share by Country in 2022
Figure 63. Europe Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 64. Europe Mesalazine API Sales Market Share by Application (2018-2023)
Figure 65. Germany Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Mesalazine API Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Mesalazine API Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 73. Middle East & Africa Mesalazine API Sales Market Share by Application (2018-2023)
Figure 74. Egypt Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Mesalazine API in 2022
Figure 80. Manufacturing Process Analysis of Mesalazine API
Figure 81. Industry Chain Structure of Mesalazine API
Figure 82. Channels of Distribution
Figure 83. Global Mesalazine API Sales Market Forecast by Region (2024-2029)
Figure 84. Global Mesalazine API Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Mesalazine API Sales Market Share Forecast by Purity (2024-2029)
Figure 86. Global Mesalazine API Revenue Market Share Forecast by Purity (2024-2029)
Figure 87. Global Mesalazine API Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Mesalazine API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Mesalazine API
Figure 2. Mesalazine API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mesalazine API Sales Growth Rate 2018-2029 (Tons)
Figure 7. Global Mesalazine API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Mesalazine API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Above 97 %
Figure 10. Product Picture of Above 98 %
Figure 11. Product Picture of Above 99 %
Figure 12. Global Mesalazine API Sales Market Share by Purity in 2022
Figure 13. Global Mesalazine API Revenue Market Share by Purity (2018-2023)
Figure 14. Mesalazine API Consumed in Tablets
Figure 15. Global Mesalazine API Market: Tablets (2018-2023) & (Tons)
Figure 16. Mesalazine API Consumed in Capsules
Figure 17. Global Mesalazine API Market: Capsules (2018-2023) & (Tons)
Figure 18. Mesalazine API Consumed in Granule
Figure 19. Global Mesalazine API Market: Granule (2018-2023) & (Tons)
Figure 20. Mesalazine API Consumed in Suppository
Figure 21. Global Mesalazine API Market: Suppository (2018-2023) & (Tons)
Figure 22. Mesalazine API Consumed in Enema
Figure 23. Global Mesalazine API Market: Enema (2018-2023) & (Tons)
Figure 24. Mesalazine API Consumed in Others
Figure 25. Global Mesalazine API Market: Others (2018-2023) & (Tons)
Figure 26. Global Mesalazine API Sales Market Share by Application (2022)
Figure 27. Global Mesalazine API Revenue Market Share by Application in 2022
Figure 28. Mesalazine API Sales Market by Company in 2022 (Tons)
Figure 29. Global Mesalazine API Sales Market Share by Company in 2022
Figure 30. Mesalazine API Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Mesalazine API Revenue Market Share by Company in 2022
Figure 32. Global Mesalazine API Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Mesalazine API Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Mesalazine API Sales 2018-2023 (Tons)
Figure 35. Americas Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 36. APAC Mesalazine API Sales 2018-2023 (Tons)
Figure 37. APAC Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 38. Europe Mesalazine API Sales 2018-2023 (Tons)
Figure 39. Europe Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Mesalazine API Sales 2018-2023 (Tons)
Figure 41. Middle East & Africa Mesalazine API Revenue 2018-2023 ($ Millions)
Figure 42. Americas Mesalazine API Sales Market Share by Country in 2022
Figure 43. Americas Mesalazine API Revenue Market Share by Country in 2022
Figure 44. Americas Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 45. Americas Mesalazine API Sales Market Share by Application (2018-2023)
Figure 46. United States Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Mesalazine API Sales Market Share by Region in 2022
Figure 51. APAC Mesalazine API Revenue Market Share by Regions in 2022
Figure 52. APAC Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 53. APAC Mesalazine API Sales Market Share by Application (2018-2023)
Figure 54. China Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Mesalazine API Sales Market Share by Country in 2022
Figure 62. Europe Mesalazine API Revenue Market Share by Country in 2022
Figure 63. Europe Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 64. Europe Mesalazine API Sales Market Share by Application (2018-2023)
Figure 65. Germany Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Mesalazine API Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Mesalazine API Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Mesalazine API Sales Market Share by Purity (2018-2023)
Figure 73. Middle East & Africa Mesalazine API Sales Market Share by Application (2018-2023)
Figure 74. Egypt Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Mesalazine API Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Mesalazine API in 2022
Figure 80. Manufacturing Process Analysis of Mesalazine API
Figure 81. Industry Chain Structure of Mesalazine API
Figure 82. Channels of Distribution
Figure 83. Global Mesalazine API Sales Market Forecast by Region (2024-2029)
Figure 84. Global Mesalazine API Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Mesalazine API Sales Market Share Forecast by Purity (2024-2029)
Figure 86. Global Mesalazine API Revenue Market Share Forecast by Purity (2024-2029)
Figure 87. Global Mesalazine API Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Mesalazine API Revenue Market Share Forecast by Application (2024-2029)
